Impax Dismissal Offers Clues On Pay-For-Delay Under Actavis
An administrative law judge earlier this month ordered the dismissal of a Federal Trade Commission action challenging an agreement between Endo and Impax to stall the launch of a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article